These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11579716)

  • 1. Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: relationships with thrombotic events.
    Seriolo B; Fasciolo D; Sulli A; Cutolo M
    Clin Exp Rheumatol; 2001; 19(5):561-4. PubMed ID: 11579716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
    Deeb A; Hamdoun S; Dababo K
    Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
    Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
    Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis.
    Seriolo B; Accardo S; Fasciolo D; Bertolini S; Cutolo M
    Clin Exp Rheumatol; 1996; 14(6):593-9. PubMed ID: 8978952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis.
    Kim KJ; Baek IW; Park KS; Kim WU; Cho CS
    Lupus; 2017 Jan; 26(1):88-94. PubMed ID: 27510601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies, free protein S levels and thrombosis: a survey in a selected population of rheumatoid arthritis patients.
    Seriolo B; Accardo S; Garnero A; Fasciolo D; Cutolo M
    Rheumatology (Oxford); 1999 Jul; 38(7):675-8. PubMed ID: 10461484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
    Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
    Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies.
    Ames PR; Margarita A; Delgado Alves J; Tommasino C; Iannaccone L; Brancaccio V
    Lupus; 2002; 11(4):208-14. PubMed ID: 12043883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis].
    Filipowicz-Sosnowska A; Rupiński R; Walewska E
    Pol Arch Med Wewn; 2007; 117 Suppl():33-8. PubMed ID: 18778017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
    Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.